Panagora Asset Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Panagora Asset Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,423	Closed	-$299K	–	1754
2021 Q3	$299K	Hold	3,423	–	–	﹤0.01%	1516
2021 Q2	$306K	Hold	3,423	–	–	﹤0.01%	1518
2021 Q1	$260K	Sell	3,423 -6,249	-65%	-$471K	﹤0.01%	1609
2020 Q4	$659K	Sell	9,672 -1,886	-16%	-$118K	﹤0.01%	1128
2020 Q3	$614K	Sell	11,558 -37,650	-77%	-$2.24M	﹤0.01%	1084
2020 Q2	$2.87M	Sell	49,208 -5,465	-10%	-$294K	0.02%	551
2020 Q1	$2.15M	Buy	54,673 +201	+0.4%	+$11.8K	0.02%	566
2019 Q4	$3.24M	Buy	54,472 +53,170	+4,084%	+$2.86M	0.01%	623
2019 Q3	$69K	Sell	1,302 -6,600	-84%	-$339K	﹤0.01%	1912
2019 Q2	$404K	Hold	7,902	–	–	﹤0.01%	1502
2019 Q1	$409K	Buy	7,902 +112	+1%	+$5.43K	﹤0.01%	1456
2018 Q4	$307K	Buy	7,790 +7,570	+3,441%	+$352K	﹤0.01%	1489
2018 Q3	$11K	Sell	220 -22,756	-99%	-$1.11M	﹤0.01%	2299
2018 Q2	$1.08M	Sell	22,976 -123,886	-84%	-$5.13M	﹤0.01%	1121
2018 Q1	$5.21M	Sell	146,862 -415,904	-74%	-$16.3M	0.02%	520
2017 Q4	$24.5M	Sell	562,766 -173,320	-24%	-$8.1M	0.09%	223
2017 Q3	$38.5M	Buy	736,086 +350,796	+91%	+$19.6M	0.15%	150
2017 Q2	$22.5M	Buy	385,290 +78,429	+26%	+$4.08M	0.09%	228
2017 Q1	$14.1M	Buy	306,861 +105,772	+53%	+$5.26M	0.06%	325
2016 Q4	$10.6M	Buy	201,089 +21,750	+12%	+$1.05M	0.05%	356
2016 Q3	$8M	Buy	179,339 +52,317	+41%	+$2.27M	0.04%	414
2016 Q2	$4.84M	Buy	127,022 +16,170	+15%	+$710K	0.02%	563
2016 Q1	$4.57M	Buy	110,852 +59,658	+117%	+$2.46M	0.02%	603
2015 Q4	$2.48M	Buy	51,194 +4,068	+9%	+$181K	0.01%	740
2015 Q3	$1.89M	Sell	47,126 -57,607	-55%	-$2.52M	0.01%	787
2015 Q2	$4.2M	Buy	104,733 +59,893	+134%	+$2.07M	0.02%	562
2015 Q1	$1.47M	Buy	44,840 +18,690	+71%	+$516K	0.01%	905
2014 Q4	$672K	Buy	+26,150	New	+$622K	﹤0.01%	1174

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Panagora Asset Management's SYNH Position: Q4 2021 in Review

Panagora Asset Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2021, closing a stake of 3,423 shares — an estimated $299K sold.

Panagora Asset Management first reported a position in SYNH in Q4 2014 and held it in 28 quarters. The position peaked at $38.5M in Q3 2017. 378 funds tracked by Wall St. Rank hold SYNH as of Q4 2021.

Panagora Asset Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2021 after selling out during the quarter.
Panagora Asset Management sold 3,423 Syneos Health, Inc. Class A Common Stock shares in Q4 2021, an estimated $299K.
Panagora Asset Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 28 quarters.
Panagora Asset Management's Syneos Health, Inc. Class A Common Stock position peaked at $38.5M in Q3 2017.
378 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2021.

Based on Panagora Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.